Biotechnology News and Research

RSS

Alnylam begins dosing in Phase I clinical trial with ALN-TTRsc for treatment of ATTR

Alnylam Pharmaceuticals a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTRsc, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).

19 Mar 2013

Online chat rooms provide beneficial forum for chronic pain sufferers

The more than 100 million Americans living with chronic pain and daily suffering often have limited outlets to talk about their conditions with others who can understand and offer comfort. Online chatrooms may provide a beneficial forum where chronic pain sufferers can openly and safely communicate, as discussed in an article in Cyberpsychology, Behavior, and Social Networking, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

19 Mar 2013

Harvard’s Wyss Institute to harness Sony DADC's expertise to advance Organs-on-Chips technologies

Today the Wyss Institute for Biologically Inspired Engineering at Harvard University and Sony DADC announced a collaboration that will harness Sony DADC's global manufacturing expertise to further advance the Institute's Organs-on-Chips technologies.

18 Mar 2013

Luminex collaborates with Merck to design companion diagnostic device for Alzheimer’s disease

WHITEHOUSE STATION known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).

From Luminex 15 Mar 2013

Women’s health before pregnancy influences health of fetus and mother-to-be: Study

A woman's health status before pregnancy is critical for the health and wellbeing of the fetus and mother-to-be. The U.S. Centers for Disease Control and Prevention has set Healthy People 2020 national objectives for women of reproductive age, and young women are making important gains toward achieving some of those health goals, while some trends are less encouraging, as reported in a study published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers.

15 Mar 2013

New therapeutic approach for bladder pain syndrome

Severe chronic pain associated with conditions such as bladder pain syndrome/interstitial cystitis often require the use of opioid medication, with the risk of dependency and serious adverse reactions.

15 Mar 2013

LCME grants provisional accreditation to FAU's Charles E. Schmidt College of Medicine

FAU's Charles E. Schmidt College of Medicine Receives Provisional Accreditation from the Liaison Committee on Medical Education - LCME is the Nationally Recognized Accrediting Authority for Medical Education Programs Leading to the Doctor of Medicine Degree in the United States and Canada.

15 Mar 2013

UNM scientists identify chemical compound that appears to control cell metastases

It's the spread of the original cancer tumor that kills most people. That's why cancer researchers vigorously search for drugs that can prevent metastases, the spread of cancer. The research team co-led by Angela Wandinger-Ness, PhD, and Larry Sklar, PhD, at the University of New Mexico Cancer Center has found a chemical compound that appears to control cell migration and adhesion, two important characteristics of metastatic cancer cells.

14 Mar 2013

Scientists to create new human monoclonal antibody targeting protein associated with cancer

Researchers have discovered a unique monoclonal antibody that can effectively reach inside a cancer cell, a key goal for these important anticancer agents, since most proteins that cause cancer or are associated with cancer are buried inside cancer cells.

14 Mar 2013

Synthesis & Solid State Pharmaceutical Centre: an interview with Dr Mary Shire, University of Limerick

This is a new research centre led by the University of Limerick that supports the pharmaceutical sector in Ireland. The centre will carry out research on the key aspects of what it takes to synthesise the pharmaceutically active molecule to isolate a pure material and to formulate this into a medicine.

14 Mar 2013

Lighthouse project focuses on regenerative medicine

A German research team led by Professor Dr. Werner E. G. M-ller of the Institute of Physiological Chemistry at the University Medical Center of Johannes Gutenberg University Mainz (JGU) and scientists from the Chinese Academy of Sciences and the Chinese Academy of Geological Sciences have launched a Chinese-German Joint Center for Bio-Inspired Materials.

14 Mar 2013

Combination of stem cell therapy and physical therapy can reverse effects of spinal cord injury

Walking is the obvious goal for individuals who have a chronic spinal cord injury, but it is not the only one. Regaining sensation and continence control also are important goals that can positively impact an individual's quality of life.

14 Mar 2013

New, inexpensive nano-biosensor can detect Listeria monocytogenes in food

The foodborne bacteria Listeria monocytogenes sickens about 2,500 people in the U.S. each year and many more worldwide, killing about 25-30% of those infected. Listeriosis is caused by eating food contaminated with L. monocytogenes, and current methods for detecting the bacteria are costly and time consuming.

13 Mar 2013

Anti-cancer drug conjugates: an interview with Dr Andreas Menrad, CSO Ablynx and Dr Chris Martin, CEO Spirogen

Antibodies and in the case of Ablynx, Nanobodies, can be raised and selected to bind with high affinity selectively to cancer cells in a tumour. Cancer cells are exquisitely sensitive to certain toxins such as the PBDs produced by Spirogen.

12 Mar 2013

Researchers identify new mechanism in onset of motor neuron diseases

The British astrophysicist Stephen Hawking is likely to be the world's most famous person living with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. ALS is a progressive disease affecting motor neurons, nerve cells that control muscle function, and nearly always leads to death.

11 Mar 2013

Business Network Services to be launched by Anglia Ruskin MedTech Campus

Companies from across the medical technology sector will be offered improved access to the NHS and global markets when the Anglia Ruskin MedTech Campus launches its Business Network Services on Wednesday, 13 March.

7 Mar 2013

USF, Saneron receive patent for transplantation method using umbilical cord blood cells

Researchers at Saneron CCEL Therapeutics and the University of South Florida have received a patent relating to a method for obtaining and using umbilical cord blood cells from a donor or patient to provide neural cells for transplantation aimed at repairing a variety of neurodegenerative diseases of the brain and spinal cord, such as Parkinson's disease, Huntington's disease, multiple sclerosis, Alzheimer's disease as well as brain and spinal cord injury.

7 Mar 2013

Emerging healthcare policy aims at reducing preventable hospital readmissions

Reducing preventable hospital readmissions is a cornerstone of emerging healthcare policy. The U.S. government has developed payment policies that will decrease payments to hospitals with excess patient readmission levels, for example.

7 Mar 2013

Scientists pinpoint neural basis for stress-related relapse in rat models

All too often, stress turns addiction recovery into relapse, but years of basic brain research have provided scientists with insight that might allow them develop a medicine to help. A new study in the journal Neuron pinpoints the neural basis for stress-related relapse in rat models to an unprecedented degree.

7 Mar 2013

Online mobile phone app for users of CME Medical’s T34 Ambulatory Syringe Pump

CME Medical, the UK’s fastest growing specialist infusion company, has launched a new online mobile phone app for users of the company’s T34TM Ambulatory Syringe Pump . The app demonstrates the company’s commitment to developing accessible education programmes for all of its customers. It incorporates information which is also available in printed Quick User Guides and helps people through the process of using the pump. The app can be used on any device with an internet connection.

6 Mar 2013

Biotechnology News and Research

Alnylam begins dosing in Phase I clinical trial with ALN-TTRsc for treatment of ATTR

Online chat rooms provide beneficial forum for chronic pain sufferers

Harvard’s Wyss Institute to harness Sony DADC's expertise to advance Organs-on-Chips technologies

Luminex collaborates with Merck to design companion diagnostic device for Alzheimer’s disease

Women’s health before pregnancy influences health of fetus and mother-to-be: Study

New therapeutic approach for bladder pain syndrome

LCME grants provisional accreditation to FAU's Charles E. Schmidt College of Medicine

UNM scientists identify chemical compound that appears to control cell metastases

Scientists to create new human monoclonal antibody targeting protein associated with cancer

Synthesis & Solid State Pharmaceutical Centre: an interview with Dr Mary Shire, University of Limerick

Lighthouse project focuses on regenerative medicine

Combination of stem cell therapy and physical therapy can reverse effects of spinal cord injury

New, inexpensive nano-biosensor can detect Listeria monocytogenes in food

Anti-cancer drug conjugates: an interview with Dr Andreas Menrad, CSO Ablynx and Dr Chris Martin, CEO Spirogen

Researchers identify new mechanism in onset of motor neuron diseases

Business Network Services to be launched by Anglia Ruskin MedTech Campus

USF, Saneron receive patent for transplantation method using umbilical cord blood cells

Emerging healthcare policy aims at reducing preventable hospital readmissions

Scientists pinpoint neural basis for stress-related relapse in rat models

Online mobile phone app for users of CME Medical’s T34 Ambulatory Syringe Pump

Biotechnology eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News